Chemogenomic approaches to drug discovery
- 18 July 2001
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 5 (4) , 464-470
- https://doi.org/10.1016/s1367-5931(00)00229-5
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Sequence of the Human GenomeScience, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Forecasting Roles of Combinatorial Chemistry in the Age of Genomically Derived Drug Discovery TargetsCombinatorial Chemistry & High Throughput Screening, 2000
- Drug Discovery in the Next MillenniumAnnual Review of Pharmacology and Toxicology, 2000
- The Impact of Genomics on Drug DiscoveryAnnual Review of Pharmacology and Toxicology, 2000
- Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic eraChemistry & Biology, 1999
- Molecular Basis for p38 Protein Kinase Inhibitor SpecificityBiochemistry, 1998
- Chemical genetics resulting from a passion for synthetic organic chemistryBioorganic & Medicinal Chemistry, 1998
- Drug Development: The role of innovation in drug developmentNature Biotechnology, 1997
- The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinaseChemistry & Biology, 1997